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Abstract
Objective: Variceal bleeding in cirrhosis is mainly due to platelet activation defect and secondary to coagulation defects. 
Secretion is an important process which release procoagulants for hemostasis. In the present investigation we have 
evaluated the secretory function of platelets in liver cirrhosis and also the simultaneous changes in cytosolic calcium (Ca2+) 
and the polymerization of actin in agonist- stimulated platelets in vitro.
Methods: Liver cirrhotic patients with (n=27) or without (n=23) bleeding complication were included in the study. Control 
subjects (n=50) were also utilized for the study to compare the analytical data. Platelets were activated by collagen in vitro 
and the secretory response was assessed by the levels of nucleotides, serotonin, pyrophosphate (PPi) and inorganic 
phosphate (Pi) secreted into the extracellular fluid of the platelet suspension at various time intervals. During the course of 
secretion the alteration in the polymerization of actin was monitored simultaneously with the changes in the cytosolic Ca2+ 
level.
Results: The secretory response of platelets to collagen was significantly low in both bleeders and non-bleeders when 
compared to that of normal subjects. During secretion, low level of actin polymerization and cytosolic Ca2+ level were 
observed in the platelets of bleeders than in non-bleeders and normal subjects. The low secretory capacity of cirrhosis 
platelets could be correlated with low levels of actin polymerization and cytosolic Ca2+. The alterations were highly sig-
nificant in the platelets of bleeders when compared to those of non-bleeders. 
Conclusion: The defective secretory activity of platelets in cirrhosis bleeders might be partly due to low polymerization of 
G-actin to F-actin which is required for platelet shape change and for the release of procoagulants. Cytosolic Ca2+ level 
seems to influence actin polymerization and thereby impairs platelet secretory response to agonists in cirrhosis patients 
with bleeding complication. (Turk J Hematol 2009; 26: 82-9)
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Özet
Amaç: Sirozun başlıca komplikasyonlarından biri trombosit aktivasyon bozukluğu ile ilişkili olan varis kanamasıdır. Bu 
araştırmada, karaciğer sirozu olan hastalardan izole edilen trombositlerin, hemostaz için prokoagülan salınımında önemli Introduction
Cirrhosis of the liver is anatomically defined to be an end-
stage liver disease characterized by fibrosis and structurally 
abnormal nodules [1]. Cirrhosis leads to multiple complications 
like ascites, gastrointestinal and esophageal variceal bleeding 
as a result of portal hypertension and platelet dysfunction [2]. 
Thrombocytopenia is a significant feature of chronic liver 
diseases including cirrhosis and attributed to passive platelet 
sequestration in the spleen. The platelet dysfunction in cirrhosis 
is probably both intrinsic to the platelets and secondary to 
soluble plasma factors. Witters et al have implicated the 
necessity of platelet research in liver diseases to provide new 
pathophysiological insights [3].
Blood hemostasis is affected by platelets by adhering to the 
sites of vascular injury, releasing compounds from their 
granules, aggregating together to form hemostatic platelet plug 
and providing procoagulant surface on their phospholipid 
membrane to arrest bleeding [4]. Defect in any one of the 
above events lead to platelet dysfunction and defective 
hemostasis. 
Human platelets are secretory cells, and exocytosis is the 
mode of secretion which results in the release of α-granules, 
lysosomes and dense granules. The nature of α-granules and 
lysosomes has been reported in many (patho) physiological 
conditions [5,6]. Normally, the secretory organelles are randomly 
dispersed in the cytoplasm of resting platelets. Upon activation, 
platelets lose their discoid shape, develop multiple pseudopods, 
and concentrate the cell organelles in the centre of the cell. 
This alteration in the physical structure is closely associated 
with the polymerization of globular or monomeric actin (G-actin) 
to filamentous actin (F-actin) that leads to secretion of 
substances into the surrounding medium [7]. 
About 3-8 dense granules are present per platelet [8,9], 
which contains serotonin, adenosine tri phosphate (ATP), 
adenosine di phosphate (ADP), calcium (Ca2+) and 
pyrophosphate (PPi) [10,11]. The contents, especially serotonin 
and ADP amplify the platelet responses induced by strong 
platelet agonists and stabilize platelet aggregates [12,13]. The 
procoagulant actions of these components are proved 
experimentally [14]. Many studies have shown that ATP has a 
complex role in the regulation of platelet aggregation [15,16]. 
Ca2+ is essential for both platelet aggregation [17] and the 
release reaction [18]. Addition of Ca2+ ionophore to platelets 
resulted in aggregation and release of stored contents from 
platelets [18]. 
We have previously reported that defective Ca2+ release 
from the internal stores may account for inhibition of platelet 
aggregation in cirrhosis [19]. Though many scientists have 
reported that platelet aggregation and adhesion are abnormal 
in liver cirrhosis of different etiology [20, 21], the study regarding 
the secretory functions of platelets in liver cirrhosis is limited. 
Hence, the present investigation was focused on evaluating 
the level of secretion of hemostatic elements simultaneously 
with changes in the level of cytosolic Ca2+ and actin 
polymerization in platelets stimulated by the agonist collagen in 
vitro. The study is also aimed to assess the relationship 
between bleeding time (BT) and the secretory capacity of 
platelets in liver cirrhosis. 
Subjects and Methods
Patients
The study comprised of fifty patients registered in the 
Department of Surgical Gastroenterology and Proctology, 
Stanley Medical College and Hospital, and the Department of 
Digestive Health Diseases, Government Peripheral Hospital, 
Chennai. Cirrhosis was confirmed by ultrasound and Doppler 
use-ultrasound. Variceal bleeding was confirmed by endoscopy. 
Patients screened for other platelet disorders not associated 
with liver complications and patients under any prescribed 
medication were excluded from the study. Patients were 
grouped as bleeders (n=27) and non-bleeders (n=23) as per 
Child-Pugh classification. The age range of the patients was 32 
to 54 years with a mean of 46±6.38 years. Age and sex-
matched healthy volunteers (n=50) between 34 to 55 years 
bir süreç olan, sekretuvar kapasitesini belirledik. Ayrıca, in vitro olarak agonistle uyarılan trombositlerdeki sitosolik kalsiyum-
daki (Ca2+) eş zamanlı değişiklikleri ve aktinin polimerizasyon durumunu da araştırdık. Bu çalışmanın amacı, karaciğer 
sirozunda trombositlerin sekretuvar fonksiyonunun aktin polimerizasyonunun seviyesinden ve sitosolik Ca2+ seviyesindeki 
değişikliklerden etkilenip etkilenmediğini değerlendirmekti.
Materyal ve Metod: Trombositler in vitro olarak kollajen ile aktive edildi ve sekretuvar cevap çeşitli zaman aralıklarında 
trombosit süspansiyonunun hücre dışı sıvısına salınan nükleotid, serotonin, pirofosfat (PPi) ve inorganik fosfat (Pi) seviyeleri 
ile değerlendirildi. Salınım boyunca, aktin polimerizasyonundaki değişimler, sitosolik Ca2+ seviyesindeki değişikliklerle eş 
zamanlı olarak izlendi.
Bulgular: İstirahat halindeki trombositlerdeki bazal serotonin seviyesi hem kanaması olan hem de kanaması olmayan 
bireylerde normal kişilerle karşılaştırıldığında anlamlı olarak düşüktü. Adenin nükleotidlerin seviyesi kanaması olan bireylerde 
anlamlı olarak düşüktü. Sirotik trombositlerin sekretuvar kapasitesi düşük olduğu bulundu ve düşük seviyelerdeki aktin 
polimerizasyonu ve sitosolik Ca2+ ile ilişkili olabilirdi. Kanaması olan bireylerin trombositlerindeki değişimler kanaması olma-
yan bireylerle karşılaştırıldığında anlamlı derecede yüksekti.
Sonuç: Sirozda trombositlerin bozuk sekretuvar aktivitesi, kısmen trombosit şekil değişikliği ve prokoagülanların salınımı 
için gerekli olan, globüler aktinin filamentöz aktine polimerizasyonunun düşük olmasına bağlı olabilir. Sitosolik Ca2+ sevi-
yesi aktin polimerizasyonunu ve böylece agonistlere karşı trombosit sekretuvar cevabını etkiliyor gibi görünmektedir. 
(Turk J Hematol 2009; 26: 82-9) 
Anahtar kelimeler: Siroz, trombosit salınımı, aktin polimerizasyonu, sitozolik kalsiyum, serotonin, adenin nükleotidler
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were used as control subjects. The clinical characteristics of 
the study groups are presented in Table I. 
The study protocol was ethically approved and the blood 
sample was collected with the consent of each patient. 
Isolation of platelets
Platelets were isolated by the method of Aster and Jandl 
[22]. Ten millilitres of fasting blood was collected by venous arm 
puncture and mixed with 1.6 ml of acid-citrate-dextrose 
solution. The blood was centrifuged at 275g for 10 min at room 
temperature to obtain platelet rich plasma (PRP). The PRP was 
again centrifuged at 400g for 5 min to remove any contaminating 
red blood cell (RBC). Then the PRP was centrifuged at 1000g 
to pellet out the platelets and washed in platelet buffer I (0.12 
M NaCl, 0.0129 M trisodium citrate and 0.03 M glucose) 
followed by washing in buffer II (0.154 M NaCl, 0.01 M Tris and 
0.001 M EDTA, pH 7.4). The washing procedure was continued 
until the pellet was red cell- free. The platelet pellet was 
suspended in platelet storage buffer containing 0.109 M NaCl, 
4.3 mM K2HPO4, 16 mM Na2HPO4, 8.3 mM NaH2PO4 and 
5.5 mM glucose, pH 7.5 and stored at 4˚C. All the estimations 
were performed under sterile conditions within 5 h of sample 
collection. 
Reagents
Fura-2AM, serotonin, DNA, DNase I, guanidine hydrochloride, 
digitonin and EGTA were purchased from Sigma-Aldrich 
Chemicals, Bangalore, India. ADP, ATP, HEPES and phenyl 
methyl sulfonyl fluoride (PMSF) were purchased from Sisco 
Research Laboratories, Mumbai, India. All other chemicals and 
reagents used were of analytical grade. 
Assay of platelet cytosolic Ca2+
Platelet cytosolic Ca2+ was measured with the fluorescent 
indicator Fura-2 by the method described by Pollock et al. [23]. 
2μM Fura-2 AM (Sigma-Aldrich Chemicals, Bangalore) was 
added to PRP and incubated for 45 min at 37°C and then 
centrifuged at 700 g for 20 min. The supernatant plasma was 
discarded and the platelet pellet was resuspended in HEPES 
buffer (140 mM NaCl, 5 mM KCl, 5mM KH2PO2,1 mM MgCl2, 
5 mM glucose and 10 mM HEPES, pH 6.5) at 37°C. The 
platelet concentrate was repeatedly washed twice and 
centrifuged at 640 g for 20 min and finally the pellet was 
resuspended in HEPES buffer, pH 7.4 at a concentration of 
1x104 cells/ml. Fluorescence intensities at 510nm emission 
were measured at 37°C using an ELICO SL174 
spectrofluorometer with the excitation wavelength of 340 and 
380 nm. The cells were lysed with 50μM digitonin followed by 
addition of 1mM CaCl2 to obtain maximal fluorescence, Fmax. 
Then, the lysed cells were added with 10mM EGTA in 20mM 
Tris base and the pH of the lysed cells was adjusted to 8.5 to 
yield the Ca2+ independent fluorescence of Fura-2, Fmin. Ca2+ 
was then calculated according to the formula, 
Ca2+ = kd x (F - Fmin)/ (Fmax - F)
Where F is the Fura-2 fluorescence of resting or stimulated 
platelets. kd was taken to be 224nM [24]. 
Assay of serotonin
Serotonin was determined by the spectrofluorometric 
method [25]. Briefly, the isolated platelets were suspended in 
5ml of ice-cold saline to wash out the adhering blood proteins 
and centrifuged at 1000g for 20 min. The washing procedure 
was repeated twice and the pure platelet pellet obtained was 
finally suspended in 3.5ml of 0.02N HCl and agitated gently to 
lyse the platelets. One ml of the lysate was diluted with 2ml of 
water and the proteins were precipitated by the addition of 
0.2ml of 10% ZnSO4 and 0.1ml of 1N NaOH. To the 
supernatant, 0.3ml of 12N HCl was added and the fluorescence 
was measured in an ELICO SL174 spectrofluorometer at 490 
nm after excitation at 385 nm. The amount of serotonin was 
determined from the calibration curve obtained by using known 
concentrations of serotonin (Sigma - Aldrich Chemicals, 
Bangalore) as the standard. 
Assay of adenine nucleotides
Adenine nucleotide content was measured by HPLC. The 
chromatographic separation was performed on a 250x4.60 
mm column packed with 10-pm silica particles to which 
octadecyl groups has been bonded. The column was eluted 
with 50mM potassium phosphate buffer, pH 7.0. Samples 
were analyzed with isocratic elution at a flow rate of 1.2 ml/min. 
Twenty microliters of sample or a standard solution was 
Annie-Jeyachristy et al.
Defective platelet secretion in liver cirrhosis Turk J Hematol 2009; 26: 82-9 84
Table 1. Clinical characteristics of subjects included in this 
study
Clinical findings  No. of cirrhotic   No. of normal
   patients  subjects
Total number  50  50
Male / female ratio  30/20  35/15
Age in years (range)  32-54  34-55
Grade (according to Child – Pugh class)    
 A    13  -
 B  12  -
 C  25  -
Ascitic 35  -
Non-ascitic 15 
Hepatic encephalophathy  6  -
Platelet count    
 <100x109 cells/L   27  -
 >100x109 cells/L  12  -
 >250x109 cells/L  11  50
Prothrombin time   
 <4  seconds  12  50
 4-6  seconds  11  -
  >6 seconds   27  -
Bleeding time   
  Normal (60-90 s)  11  50
  Abnormal (90-125 s)  39  -manually injected using Hamilton syringes. Chromatographic 
peaks in experimental samples were detected by absorbance 
at 254 nm and identified by comparison to known standards. 
Assay of PPi and inorganic phosphate (Pi)
The enzymatic method of determination of PPi content was 
based on the oxidation of NADH to NAD per mole of PPi 
consumed which was measured spectrophotometrically at 
340nm [26]. The Pi content was measured spectrophotometrically 
at 620nm [27].
Preparation of platelets for secretion studies
The platelet count in each group was adjusted to 2.5x109 
cells/μl. The platelets were activated with 2μM collagen and the 
reaction was terminated at different time intervals (0, 3, 6, 9 
min) by mixing the sample with one third volume of ice-cold 
0.633M formaldehyde in 0.05M EDTA for serotonin and one-
third volume of 0.15M NaCl for adenine nucleotides and 10% 
TCA for PPi and Pi determinations. The contents were kept on 
ice for up to 60 min and then centrifuged at 12,000g for 2 min 
at room temperature [28]. The extracellular fluid of the platelet 
suspension was used for the estimation of serotonin, adenine 
nucleotides, PPi and Pi as described previously. 
Isolation of platelet cytoskeleton
Platelet cytoskeleton was obtained from the isolated 
platelets [29] with slight modifications. Briefly, washed platelets 
(1:1 in platelet storage buffer) was added with 10 vol of Triton 
X-100 solubilization buffer (1% Triton X-100, 40mM KCl, 10mM 
imidazole-chloride, 10mM EGTA, 2mM NaN3, pH 7.0) and 
mixed by inversion. The flocculent precipitate was cooled on 
ice for 12 min and collected by centrifugation at 3000g for 2 
min. The translucent platelet membrane pellet was carefully 
collected from the microfuge tube and used for the estimation 
of G- and total actin content. The isolated platelets after 
activation with 2μM collagen were lysed with Triton X-100 
solubilization buffer at different time intervals and processed 
similarly for the estimation of G-, F- and total actin content. 
Assay of actin content
Measurement of unpolymerized (G- actin) and total actin 
was done by DNase inhibition assay [30] with slight modifications 
[7] to stabilize the inhibitory activity of the platelet lysate. Briefly, 
platelet suspension was lysed with equal volume of ice-cold 
Triton X-100 lysis buffer (2% Triton X-100, 10mM EGTA and 
100mM Tris-HCl, pH 7.4). About 50-μl aliquot was immediately 
removed, mixed with equal volume of dissociating buffer (1.5 M 
guanidine-HCl, 20 mM Tris-HC1, 1 M sodium acetate, 6 mM 
CaC12, 1 mM Na-ATP, pH 8.4), and incubated on ice for 15 
min. The contents were then added with 20 μl of DNase I (beef 
pancreas, DN 100: Sigma-Aldrich Chemicals, Bangalore) at a 
concentration of 0.2 mg/ml in 50 mM Tris-HC1, pH 7.5, 0.1 mM 
CaCI2, 10 μM PMSF. Sixty μl of this mixture was removed and 
added to 3 ml of DNA (calf thymus, type I: Sigma-Aldrich 
Chemicals, Bangalore) at a concentration of 40 μg/ ml in 100 
mM Tris-HC1, 4 mM MgSO4, 1.8 mM CaCl2, pH 7.5. Total actin 
concentration was determined after treating the samples at 0°C 
with an equal volume of 1.5 M guanidine-HCI in 1.0 M sodium 
acetate/l mM CaCl2/1 mM ATP/20 mM Tris HCI, pH 7.5. The 
change in absorbance at 260 nm was recorded for 5 min. 
Standard curves were generated in exactly the same way 
using purified rabbit skeletal muscle actin. The DNase inhibitor 
activity measured in the absence of guanidine- HCI represents 
the amount of G- actin in a sample and the activity after 
treating the sample with guanidine-HCI measures total actin. 
From the difference between the total actin and the G- actin 
content, F- actin content was determined. G- actin and F- actin 
content were expressed as % of total actin content. 
Statistical analyses
The Data was analyzed by using commercially available 
statistic software package (SPSS for Windows V.12.0). ANOVA 
test was applied for statistical analysis. Spearman’s rank 
correlation analysis was conducted for the correlation of paired 
values. Results were presented as mean ± SD. Statistical 
p-value <0.05 was used to establish significance.
Results
Concentrations of serotonin, adenine nucleotides, cytosolic 
Ca2+, PPi, Pi and G- actin content in unstimulated platelets. 
The levels of serotonin, adenine nucleotides, ATP and ADP, 
PPi, Pi, cytosolic Ca2+ and cytoskeletal G-actin content of 
unstimulated whole platelets are presented in Table 2. There 
was no significant difference in the levels of adenine nucleotides, 
PPi and Pi between non-bleeders and normal subjects but a 
significant decrease in the levels of adenine nucleotides was 
observed in bleeders when compared with normal subjects. 
There was a significant decrease in the concentrations of 
serotonin and Ca2+ between patients with bleeding complication 
and those without bleeding complication. G- actin content 
determined by DNAse I inhibition assay showed no significant 
changes in the level of actin contents in cirrhotic patients when 
compared to that of normal subjects. 
Secretory response of platelets to collagen
To measure the secretory response of the platelets obtained 
from experimental subjects, the platelets were activated with 
2μM collagen and the level of secretion was measured in terms 
of release of serotonin, adenine nucleotides, PPi, and Pi (Figure 
1). There was a significant decrease in the levels of serotonin, 
ADP, PPi and Pi secreted by platelets of both categories of 
cirrhosis patients when compared to those of normal subjects. 
ATP/ ADP ratio showed a significant elevation in cirrhosis 
patients when compared to normal subjects. The elevation 
was more significant in bleeders when compared to non-
bleeders. The level of polymerized actin (F-actin) was found to 
be significantly low in cirrhotic bleeders when compared to that 
of normal subjects and non-bleeders (Figure 2). 
Time-dependent secretory response of platelets 
to collagen
The response of platelets to agonist was measured in terms 
of serotonin and adenine nucleotides, ATP and ADP at different 
time intervals (Figure 3). The time-dependent secretory 
response of cirrhotic platelets to collagen showed that maximum 
secretion of serotonin and ADP was reached in normal platelets 
earlier than that of cirrhotic platelets. ATP secretion was found 
to be delayed in normal platelets whereas it showed a steady 
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platelets of cirrhosis patients, though there was a time-
dependent raise in ADP and serotonin levels, the net secretion 
was lesser than those of normal subjects. But the amount of 
ATP secretion was higher than that of normal subjects. 
Time-dependent changes in the level of cytosolic 
Ca2+ and polymerization of actin during secretion 
The changes in the cytosolic Ca2+ were monitored at 
regular time intervals during the course of secretion (Figure 4). 
In normal platelets, there was a proportionate increase in the 
level of cytosolic Ca2+ as the procoagulants release proceeded. 
There was a time dependent, but, low and delayed response 
shown by cirrhotic platelets. The level of increase was not 
significant in cirrhotic bleeders (Figure 4). Cirrhotic patients 
without bleeding complications showed elevation in the level of 
cytosolic Ca2+ during the secretion process. 
During collagen-induced secretion, the time course of actin 
polymerization was also monitored simultaneously (Figure 5). In 
cirrhotic cells the level of actin polymerization was significantly 
lower than that of normal platelets and reflected in the level of 
F-actin, the polymerized form.
Spearman correlation analyses showed that there was a 
positive correlation between BT-ATP/ADP ratio, Ca2+-serotonin 
and Ca2+-F-actin. A significant negative correlation was 
observed between the paired values of BT-Ca2+ and BT - 
serotonin (Table 3). 
Discussion
Platelets play pivotal roles in the hemostatic process 
including detection of vascular lesions, adherance at sites of 
injury, recruitment of additional platelets and consolidation into 
a hemostatic plug [31]. Most of the cirrhosis patients considered 
in the study had low platelet count and altered bleeding time. 
Thrombocytopenia is generally associated with deficient platelet 
function and thereby the related abnormality [3]. In our study 
the defective secretory response observed in all the cirrhosis 
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Table 2. Adenine nucleotides, serotonin, calcium, pyrophosphate, inorganic phosphate and membrane G -actin content in the unstimulated 
platelets of cirrhotic patients and in normal healthy volunteers. (mean ± SD)
Parameters  Normal subjects (n=50)  Cirrhotic patients (n=50)
     Non-bleeders (n=23)  Bleeders (n=27) 
Cytosolic Ca2+ (nM/104 cells)  28±3.0  24±2.8*  17±2.0**#
Serotonin (nM/mg protein)  2.0±0.41  1.8±0.21*  1.7±0.25*#
ATP (nM/mg protein)  20.5±3.1  19.5±2.0NS 17.6±1.9*#
ADP (nM/mg protein)  12.5±1.9  11.5±1.8NS 10.0±1.6*#
ATP/ADP ratio  1.64±0.18  1.70±0.19NS 1.76±0.19NS#
PPi (nM/mg protein)  6.0±0.08  5.7±0.08NS 5.6±0.08NS
Pi (nM/mg protein)  12.6±2.1  12.0±2.0NS 11.7±2.0NS
G- actin content (% Total actin)  80±8.2  75±7.7NS 70±7.3NS
**p < 0.001, *p < 0.05, NS – non-significant, when compared with normal subjects
##p < 0.001, #p < 0.05, NS-non-significant, when compared with non-bleeders.
Ca2+, calcium; ATP, adenosine triphosphate; ADP, adenosine di phosphate; PPi, pyrophosphate; Pi, inorganic phosphate; G-actin, Globular actin;
Table 3. Spearman rank correlation coefficient between 
BT-serotonin, BT – ATP/ADP ratio, BT – Ca2+, Ca2+ - sero-
tonin and Ca2+ - F- actin 
Variables rs
BT – serotonin  - 0.50
BT – ATP/ADP ratio  0.52
BT – Ca2+ -  0.55
Ca2+ - serotonin  0.48
Ca2+ - F- actin  0.57
All correlation coefficient (Spearman rho-rs) values were significant at P <0.05
BT, bleeding time; ATP, adenosine tri phosphate; ADP, adenosine di phos-
phate; Ca2+,  calcium; F-actin, filamentous actin Figure 1. Levels of adenine nucleotides, serotonin, pyrophosphate and 
inorganic phosphate secreted by stimulated platelets. Aliquots of platelets 
(2.5x109 cells/μl) from normal subjects         and cirrhotic non-bleeders                                           
            and bleeders              were treated with 2μM collagen and the reac-
tion was arrested at 9th min and the secreted adenine nucleotides, serotonin, 
pyrophosphate and inorganic phosphate were measured as mentioned in 
methods section. Values are expressed as mean ± SD for n = 20 in each group. 
Statistically significant variation is expressed as ** p < 0.001, *p < 0.05, NS – non-
significant, when compared with normal subjects, ##p < 0.001, #p < 0.05, 
NS- non-significant, when compared with non-bleeders. (a - nM/mg protein)patients and more significantly in patients with bleeding 
complication could be correlated with the platelet count. 
ADP, secreted from dense granules induces other platelets 
to degranulate and potentiate coagulation. Furthermore, ADP in 
conjunction with thromboxane A2 and thrombin cause platelet 
contraction and the formation of a secondary hemostatic plug to 
bind fibrinogen which acts as a crosslink between the platelets 
allowing aggregation. Other molecules within platelet dense 
granules include ATP and ionized Ca2+ which are necessary for 
several steps of the coagulation cascade. Serotonin plays an 
essential role as vasoconstrictor to minimize the loss of blood. 
Studies in patients with dense granule abnormality indicate that 
deficiency in serotonin, ATP, ADP and Ca2+ are highly correlative 
and the alterations are interrelated [10]. 
We could find a significant alteration in the levels of 
serotonin and adenine nucleotides in resting platelets of 
cirrhotic bleeders. When the platelets were activated with 
collagen there was a significant change in the levels of secretion 
of serotonin, ADP and ATP in liver cirrhotic patients with 
bleeding complications when compared to those of non-
bleeders and normal subjects. Our results show that both 
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Figure 2. Levels of G- and F-actin content in stimulated platelets 
Aliquots of platelets (2.5 x 109 cells/μl) from normal subjects            and 
cirrhotic non-bleeders            and bleeders           were treated with 2μM 
collagen and the reaction was arrested at 9th min and the platelet G- and 
F- actin content were measured using DNase I inhibition assay. Values are 
expressed as mean ± SD for for n = 20 in each group. Statistically significant 
variation is expressed as *p<0.001 when compared with normal subjects 
and #p < 0.001, when compared with non-bleeders
Figure 3.Time-dependent secretion of serotonin and adenine nucleotides 
in terms of ATP and ADP by platelets in response to collagen 
Aliquots of platelets (2.5 x 109 cells/μl) from normal subjects            and 
cirrhotic non-bleeders           and bleeders            were treated with 2μM 
collagen and platelet secretion in terms of serotonin (nM/mg protein) and 
adenine nucleotides (ATP and ADP, nM/mg protein) at different time inter-
vals was measured. Values are expressed as mean ± SD for for n = 20 in 
each group. ** p < 0.001, *p < 0.05, NS – non-significant, when compared 
with normal subjects, ##p < 0.001, #p < 0.05, when compared with non-
bleeders
Figure 4. Time- dependent changes in the level of cytosolic Ca2+ during 
secretion by stimulated platelets 
Aliquots of platelets (2.5 x 109 cells/μl) from normal subjects and cirrhotic 
non-bleeders and bleeders were treated with 2μM collagen and aliquots 
containing 1x104 platelets from normal subjects and cirrhotic non-bleeders 
and bleeders were withdrawn at different time intervals and calcium release 
using Fura-2AM was measured. Values are expressed as mean ± SD for 
for n=20 in each group. ** p < 0.001, *p < 0.05, when compared with 
normal subjects, #p < 0.001, when compared with non-bleeders
Figure 5. Time-dependent polymerization of actin by platelets in response 
to collagen in stimulated platelets 
Aliquots of platelets (2.5 x 109 cells/μl) from normal subjects            and 
cirrhotic non-bleeders           and bleeders          were treated with 2μM 
collagen and aliquots were withdrawn at different time intervals and platelet 
actin polymerization was measured by DNAse I inhibition assay. (G- actin, 
globular actin; F- actin, filamentous actin). Values are expressed as mean ± 
SD for n = 20 in each group. ** p < 0.001, *p < 0.05, when compared with 
normal subjects, #p < 0.001, when compared with non-bleedersserotonin and nucleotide secretion is low in cirrhotic bleeders 
which can be correlated with hemostatic disturbances. 
Serotonin is not synthesized in platelets but is actively taken 
up from the plasma and accumulates in dense granules where 
it is likely complexed with ATP and potentially with Ca2+ [32]. 
The serotonin released by exocytosis is relatively stable and 
functions as a weak agonist on serotonin receptors (-5HT2- 
receptors) [33]. Dense granule derived serotonin, therefore acts 
to activate additional platelets and thus recruits them into 
aggregates [31]. The positive feedback effect of serotonin may 
be of secondary importance to its vasoconstrictive action 
which reduces the blood flow at the site of injury and thereby 
limits blood loss [32]. 
In normal platelets, the level of ADP secretion is significantly 
greater than that of ATP. In cirrhotic subjects, ATP secretion was 
found to be elevated when compared to that of ADP. ATP 
competitively inhibits ADP action [34] and thus regulates platelet 
activation. Elevated ATP secretion has been reported in various 
inflammatory and shock conditions, primarily as a consequence 
of nucleotide release from platelets, endothelium and blood 
vessel wall [35-37]. In this investigation we have shown that in 
cirrhotic condition, platelets secrete elevated level of ATP, which 
antagonize the action of ADP, and this might contribute to the 
platelet activation defect in liver cirrhosis. Our observation also 
showed that the secretory response of platelets to agonists is 
delayed in liver cirrhosis. It can be correlated with similar 
activation of platelets in vivo by the endogenous collagen 
exposed on the ruptured vascular walls. 
Our results show that the activation of platelets by agonists 
was associated with parallel elevation in the level of Ca2+ in 
normal platelets. The level of elevation was not significant in the 
platelets of cirrhosis patients. So, the altered secretory capacity 
of cirrhotic platelets may be accounted by the low availability of 
Ca2+ which functions in a diverse manner to regulate the 
secretory process. In our previous study, we have reported that 
the enzyme activity is significantly low in cirrhotic platelets that 
cannot affect Ca2+ efflux required for activation [38].
The role of cytosolic Ca2+ in platelets has been studied in 
various pathophysiological conditions. It has been found that 
micromolar levels of Ca2+ ions added to the extracellular 
medium elicit secretion of serotonin in the presence of millimolar 
levels of Mg-ATP. Ca2+ transport inhibitors were shown to 
interrupt with the secretion of serotonin by platelets [39]. The 
state of assembly of the platelet cytoskeleton appears to be 
under the control of intracellular concentration of free Ca2+. The 
ability of Ca2+ to control the assembly and disassembly of the 
platelet cytoskeleton provides a mechanism for cytoskeletal 
involvement in shape change and pseudopod formation during 
platelet activation [40]. Secretory granules bound to the end of 
an actin filament can move to the plasma membrane as a result 
of the contraction of acto-myosin that is activated by Ca2+ ions 
[41]. In this investigation we have studied the variation in the 
level of calcium release between bleeders and non-bleeders. 
When compared to non-bleeders, bleeders have shown a slow 
release of Ca2+ from the subcellular organelles to cytoplasm 
that might affect secretory action of platelets. 
It is necessary for the platelet to possess an actin 
cytoskeleton that can be rapidly restructured upon activation 
[42]. It has also been reported that an actin-binding protein, 
inhibited from interacting with actin by a rise in Ca2+ may be a 
factor that permits the rapid organization of the platelet actin 
cytoskeleton. Few investigators have suggested that 
actomyosin-dependent granule centralization and membrane 
fusion act synergistically to facilitate granule secretion [43-45]. 
It has been demonstrated that agonist induced activation 
results in conversion of unpolymerised, monomeric, globular 
G- actin to filamentous F- actin [46]. The finding of the present 
study reveal that normal unstimulated platelets exhibit 80% of 
their total actin in the monomeric state but the cirrhotic platelets 
showed a non-significant decrease in the total and G- actin 
contents. When the cirrhotic platelets were stimulated, F- actin 
formation was significantly lower than that of normal platelets. 
The low level of formation of polymerized F- actin in the 
platelets of liver cirrhotic patients as observed in our investigation 
may be associated with the decreased granule secretion in 
cirrhotic bleeders. However, the exact role of actin polymerization 
in platelet granule secretion remains to be elucidated in liver 
cirrhosis. A study on the structural and morphological changes 
of cirrhotic platelets on activation has been undertaken in our 
laboratory to give supportive evidence for the present work. 
The statistical correlation between bleeding time and the 
various parameters analysed reveal that bleeding time, a reliable 
indicator of platelet functions is negatively correlated with the 
secretory response evidenced by the levels of nucleotide and 
serotonin secretion. BT was also found to have significant 
positive correlation with the level of ATP, an inhibitor of platelet 
secretion. Cytosolic Ca2+ level is found to have a parallel 
correlation with the levels of serotonin secretion and F- actin 
formation. This study reveals that actin polymerization is also 
defective in the platelets of patients with cirrhosis and this may 
be responsible for the low secretory response to agonists.
Conclusion
It is concluded that the secretion of hemostatic elements by 
the platelets in response to the agonist collagen is defective in 
liver cirrhosis. Low Ca2+ release from the internal store and 
impaired actin polymerization seem to alter the normal secretory 
capacity of platelets in liver cirrhosis associated with bleeding 
complication. 
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